AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| CRO | Ann: Results of Meeting | 24/04/18 | 0 | 63 | |||
|
|||||||
| CRO | Ann: Operational Update | 24/04/18 | 31 | 4.1K | |||
|
|||||||
| CRO | Sell side thin | 13/04/18 | 114 | 19K | |||
|
|||||||
| CRO | Ann: Withdrawal of Resolution at General Meeting | 23/03/18 | 1 | 400 | |||
|
|||||||
| CRO | Ann: Notice of General Meeting/Proxy Form | 22/03/18 | 0 | 184 | |||
|
|||||||
| CRO | Ann: Section 708A Notice | 06/03/18 | 0 | 227 | |||
|
|||||||
| CRO | Ann: $2.6m Capital Raising to Fast Track Growth Opportunities | 06/03/18 | 38 | 6.6K | |||
|
|||||||
| CRO | Ann: Completion of Private Placement & Appendix 3B | 05/03/18 | 0 | 236 | |||
|
|||||||
See All Discussions
ASX News